Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder.

about

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder.

Item

http://www.wikidata.org/entity/Q42261505

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Meta-Analysis of the Efficacy ...... enacin for Overactive Bladder.

@en

Meta-Analysis of the Efficacy ...... enacin for Overactive Bladder.

@nl

type

Item

label

Meta-Analysis of the Efficacy ...... enacin for Overactive Bladder.

@en

Meta-Analysis of the Efficacy ...... enacin for Overactive Bladder.

@nl

prefLabel

Meta-Analysis of the Efficacy ...... enacin for Overactive Bladder.

@en

Meta-Analysis of the Efficacy ...... enacin for Overactive Bladder.

@nl

P1476

Meta-Analysis of the Efficacy ...... fenacin for Overactive Bladder

@en

P2093

Chu Liu

http://www.w3.org/2001/XMLSchema#string

Ruihua Liu

http://www.w3.org/2001/XMLSchema#string

Yankai Xu

http://www.w3.org/2001/XMLSchema#string

Yuanshan Cui

http://www.w3.org/2001/XMLSchema#string

Zhenli Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women.

Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.

Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors

The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.

Social, economic, and health utility considerations in the treatment of overactive bladder.

The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials.

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).

Pharmacokinetic drug interaction study between overactive bladder drugs mirabegron and tolterodine in Japanese healthy postmenopausal females.

P304

212-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5213/INJ.1734934.467

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28954464

http://www.w3.org/2001/XMLSchema#string

P932

5636960

http://www.w3.org/2001/XMLSchema#string